SCHEMBL641100

SCHEMBL641100

O=C(O)N1CCC2(CC1)CCC(O)(c1cccnc1)CC2

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.64
LMNA P02545 3/20 0.64
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
PKM P14618 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.54
CYP3A4 P08684 2/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
CYP2D6 P10635 1/20 0.50
HPGD P15428 1/20 0.50
CHRM2 P08172 1/20 0.46
POLB P06746 1/20 0.46
OPRM1 P35372 1/20 0.45
OPRD1 P41143 1/20 0.45
OPRK1 P41145 1/20 0.45
OPRL1 P41146 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3441676 0.92 ALDH1A1 (0.75) ALDH1A1LMNAMEN1KMT2APKM
SCHEMBL3442360 0.83 ALDH1A1 (0.67) ALDH1A1LMNAMEN1KMT2APKM
SCHEMBL640760 0.82 ALDH1A1 (0.53) ALDH1A1LMNAMEN1KMT2APKM
SCHEMBL23089800 0.80 ALDH1A1 (0.58) ALDH1A1LMNAMEN1KMT2APKM
SCHEMBL3441871 0.79 ALDH1A1 (0.54) ALDH1A1LMNAMEN1KMT2APKM
SCHEMBL3441634 0.77 ALDH1A1 (0.52) ALDH1A1LMNAMEN1KMT2APKM
SCHEMBL23647599 0.77 ALDH1A1 (0.52) ALDH1A1LMNAMEN1KMT2APKM
SCHEMBL3598151 0.76 ALDH1A1 (0.51) ALDH1A1LMNAMEN1KMT2APKM
SCHEMBL16915680 0.76 ALDH1A1 (0.51) ALDH1A1LMNAMEN1KMT2APKM
SCHEMBL639657 0.75 CHRNB2 (0.43) ALDH1A1LMNAMEN1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119805-B2 Substituted disulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-21 US disclosed
EP-2350003-A1 SUBSTITUTED DISULFONAMIDES AS BRI-MODULATORS Grünenthal GmbH (DE) 2011-08-03 EP disclosed
US-20100152158-A1 Substituted Disulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-06-17 US disclosed
WO-2010051977-A1 SUBSTITUTED DISULFONAMIDES AS BRI-MODULATORS Grünenthal GmbH (DE) 2010-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152158-A1 Substituted Disulfonamide Compounds BDKRB1, BDKRB2, BRS3 ALDH1A1 1278/4885LMNA 3782/4885MEN1 1203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.